The U.S. Food and Drug Administration (FDA) held a webinar to clarify its recent Guidance for Industry on Infant Formula Enforcement Discretion Policy, which is part of FDA’s efforts to mitigate the infant formula shortage in the U.S.

The Codex Alimentarius Commission is developing a new guidance on food fraud, with input from the Global Food Safety Initiative. The guidance is expected to be published in 2024 or 2025.

The U.S. Food and Drug Administration (FDA) has amended its food additive regulations and issued a request for information regarding phthalates in response to petitions requesting that FDA address the substances in food packaging and food contact surfaces

Gillian Kelleher, President and CEO of Kelleher Consultants LLC, will serve as Chairperson for the Educational Advisory Board (EAB) for the 2023 Food Safety Summit, produced by Food Safety Magazine and BNP Media. 

Safe Food for Infants in the EU and China (SAFFI) recently published three papers that lay new groundwork for advancing global infant food safety.

A recent study has demonstrated the potential of competitive exclusion cultures in controlling Campylobacter jejuni in broiler chickens.

The U.S. Food and Drug Administration and Stop Foodborne Illness joined forces to present a webinar, titled, “Building a Coalition of Food Safety Culture Champions Across Your Organization.”

Researchers from the University of Georgia received a grant from the U.S. Department of Agriculture’s National Institute of Food and Agriculture to study how antimicrobial blue light can be used in food processing facilities to combat pathogenic biofilms and viruses.

Colorado School of Public Health researchers found that investments in state public health programs significantly affect states’ levels of foodborne illness outbreak reporting.

In light of the current infant formula supply shortage, the U.S. Food and Drug Administration (FDA) will enter a consent decree with Abbott Nutrition that will allow the company to resume production of formula products at its Sturgis, Michigan facility. FDA also released a guidance that will allow formula manufacturers and importers greater flexibility.